It has been reported that TGF-β attenuates tumour response to PD-L1 blockade by restricting T cell infiltration27, and combined blockade of IL-6 and PD-1/PD-L1 signalling exerts synergistic antitumour effects28. The gene discussed is TGFB1; the disease is neoplasm.